Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Nuvectis Pharma Inc.
NVCT | US
8.90
USD0.11
1.25%
NVCT | US
Loading StockChartView...
About Nuvectis Pharma Inc.
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
8.90
Open
8.76
High
9.21
Low
8.52
Nuvectis Pharma Inc. a biopharmaceutical company focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. The company develops NXP800 a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900 a small molecule drug candidate that inhibits the Proto-oncogene c-Src and YES1 kinases. It has license agreement with the CRT Pioneer Fund for the NXP800 and any of related derivatives; and the University of Edinburgh for the NXP900 and any of associated derivatives. The company was formerly known as Centry Pharma Inc. and changed its name to Nuvectis Pharma Inc. in July 2021. Nuvectis Pharma Inc. was incorporated in 2020 and is based in Fort Lee New Jersey.
View LessNVCT | US
Risk
46.7
Sharpe
-0.35
Luna's Score
51/100
Recommendation
Hold
Luna says (NVCT | US)
What's Working
Positive Momentum
Strength based on increasing price with high volume
Low Market Beta (-0.4 to 0.8)
What's not Working
High Short-term Volatility
Microcap (<300M USD)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
56.0%1 month
46.7%3 months
44.4%6 months
54.3%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
11.32
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-7.38
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-
MarketCap
166.01M
MarketCap(USD)
166.01M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-128.44
Short ratio
11.11
Short perc.
10.43
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
1.13
Range1M
2.04
Range3M
2.71
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.35
Price X volume
641.31K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -7.38 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 11.32 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 44.35 | 72.80 | Lower Risk |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 166.01M | 3.66B | Emerging |
